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Schwann cell proliferation is critical for the regeneration of injured nerves. Dilongs are widely used in Chinese herbal medicine to
remove stasis and stimulate wound-healing functions. Exactly how this Chinese herbal medicine promotes tissue survival remains
unclear.Theaimofthepresent study wasto investigate themolecular mechanismsby which Dilong promote neuron regeneration.
Our results show that treatment with extract of Dilong induces the phosphorylation of the insulin-like growth factor-I (IGF-
I)-mediated phosphatidylinositol 3-kinase/serine-threonine kinase (PI3K/Akt) pathway, and activates protein expression of cell
nuclear antigen (PCNA) in a time-dependent manner. Cell cycle analysis showed that G1 transits into the S phase in 12–16 h, and
S transits into the G2 phase 20 h after exposure to earthworm extract. Strong expression of cyclin D1, cyclin E and cyclin A occurs
in a time-dependent manner. Small interfering RNA (siRNA)-mediated knockdown of PI3K signiﬁcantly reduced PI3K protein
expression levels, resulting in Bcl2 survival factor reduction and a marked blockage of G1 to S transition in proliferating cells.
These results demonstrate that Dilong promotes the proliferation and survival of RSC96 cells via IGF-I signaling. The mechanism
is mainly dependent on the PI3K protein.
1.Introduction
Nerve regeneration is a complex physiological response
that takes place after injury. In mammals, central neurons
without myelin sheaths are very diﬃcult to regenerate. In
contrast, the axons of neurons in the peripheral nervous
system are surrounded by myelin sheaths and are, therefore,
easiertoregenerate[1].ImmatureSchwanncellsdiﬀerentiate
into a myelinating phenotype, laying down a myelin sheath
around the axon of neurons in the peripheral nervous
system, as well as proliferate and migrate into the injured
nerve area to support axonal re-growth [2]. Schwann cell
proliferation is crucial for successful nerve regeneration [3].
However,littleisknownaboutthesignalingmechanisms that
regulate Schwann cell proliferation.
Insulin-like growth factor-I (IGF-I) is a polypeptide
hormone synthesized by proliferating Schwann cells [4]. It is
secreted in response to growth hormone to stimulate tissue2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: IGF-I-mediated PI3K/Akt signal pathway activation time
course for Schwann cell treated with Dilong extract. RSC96 cells
were treated with 125μgml
−1 Dilong extract for diﬀerent times as
indicated, and the protein expression of IGF-I was determined by
western blot. α-tubulin was used as a loading control.
growth [5]. The IGF-I level elevation increases sympathetic
neuronproliferationinvivo[6].Inaddition,IGF-Istimulates
the growth and diﬀerentiation of fetal neurons [7]a n d
increases neurite sprouting and outgrowth in vitro [8, 9].
IGF-I has been shown to function as a progression factor in
the cell cycle [10], promoting G1/S cell cycle progression via
the phosphatidylinositol 3-kinase/serine-threonine kinase
(PI3K/Akt) pathway, resulting in DNA synthesis and cell
proliferation [11]. Interestingly, IGF-I not only stimulates
proliferation but also promotes survival in a number of
cell types [12]. Moreover, IGF-I acts as a therapeutic target
for the treatment of peripheral nerve injury and motor
neuron diseases [13]. This hormone protects neurons in
the peripheral nervous system from apoptosis by activating
the PI3K/Akt pathway, which in turn phosphorylates Bad
and activates Bcl2, an anti-apoptotic protein that interferes
with the activation of caspases [14–16]. In vivo,t h es i g n a l
cascade for early upregulation of IGF-I was shown to
promote retinal ganglion cells (RGCs) survival and axonal
regeneration through the PI3K/Akt system after optic nerve
injury in goldﬁsh [16]. These data strongly indicate that
IGF-I is an important molecule for controlling regeneration
after nerve injury. Furthermore, Maurel and Salzer [17]
found that inhibition of PI3K activation completely blocked
Schwann cell proliferation and survival. Collectively, we
investigated the PI3K/Akt signal pathway mediating IGF-
I-induced survival and proliferation in Schwann cell in
response to the earthworm extract stimulus.
With a history of several thousand years, the pharmacol-
ogy and clinical application of traditional Chinese medicine
has been well documented. Several Chinese medicines have
been identiﬁed as enhancing neuron regeneration [18].
Therefore, neuron regrowth induction using Schwann cells
and herbal medicine has good potential for treating injured
nerves. The Dilong is a widely used Chinese herbal medicine
and has been shown to have a dense nutritional content [19,
20]. Previous Dilong studies have shown its antithrombotic
[21], hepatoprotective [19], anticancer [22]a n ds c a rw o u n d
healing characteristics [23]. Lumbrokinase, a novel prote-
olyticenzyme [24], extracted from the Dilong, has beenused
to treat stroke and cardiovascular diseases [25]. Moreover,
Dilong tissue homogenates have revealed a glycolipoprotein
mixture referred to as G-90, composed of macromolecules.
The G-90 mixture contains IGFs, immunoglobulin-like
growth factor, serine proteases and epidermal growth factor
(EGF) [26–31]. Previous studies on G-90 have shown that
it promotes cell proliferation [27]a n da d h e s i o n[ 29], has
antibacterial [32], ﬁbrinolytic and anticoagulant activities
[26],andstimulatesthecellularimmunesystem[29].In vivo,
nanogram quantitiesofG-90 applieddirectlytoskinwounds
have been found to stimulate the synthesis of epidermal
growth factor (EGF) and ﬁbroblast growth factor (FGF) and
to increase cell proliferation, leading to wound healing [33].
Furthermore, it was also shown that G-90 contains IGF that
inducedcell proliferationin vitro [27]. Recently,experiments
further found that a mixed prescription of liquid extracted
from Dilong was more eﬀective at improving sciatic nerve
function index, motor nerve conductive velocity and the
number of myelinated sciatic nerve ﬁbers of regenerated
nerve after injury [34]. Whether Dilong has a nerve survival
eﬀect and proliferation-enhancing eﬀect on Schwann cell is
unknown. This study investigated the mechanisms by which
Dilong promotes proliferation and survival of Schwann cell.
2.Methods
2.1.Dilong Extraction. Spray-driedpowderofDilong,Phere-
tima aspergillum (Annelida, Oligochaeta, Lumbricidae), was
purchased from Wann Guo Pharmaceutical Co., Ltd, Tainan,
Taiwan, Republic of China, Cat. 2467. Dilong powder (2g)
was dissolved in 10ml of 70% ethanol and left at room
temperature for 24h. The next day the clear supernatant
fraction was collected after centrifugation at 370g (Kubota,
Tokyo, Japan) for 20min. The solvents were then evaporated
in a water bath at 37◦C for 4h. The extract was centrifuged
for 5min at 2290g at 4◦C and the supernatant was ﬁltered
through a 0.22-μm microspin ﬁlter just prior to the exper-
iments. The concentrations used for RSC96 cells treatment
in the in vitro model were 0, 31.25, 62.5, 125, 250, 500 and
1000μgml
−1. All solutions were stored at −80◦C.
2.2.Cell CultureandTreatments. RSC96cellswerepurchased
from the American Type Culture Collection (ATCC) and
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM)
supplemented with 10% fetal bovine serum (FBS), 4mMl-
glutamate, 1.5gl
−1 sodium bicarbonate and 1% non-
essential amino acids (NEAA) in a humidiﬁed atmosphere
of 5% CO2 and 95% air. RSC96 cells cultures were treated at
the indicated times with indicated concentrations of Dilong
extract.Evidence-Based Complementary and Alternative Medicine 3
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Figure 2:Dilongextract induce theexpression ofPCNA andpromoteG1 progression.RSC96 cells were stimulatedfor24hwith125μgml
−1
Dilong extract. The protein expression of PCNA was determined by western blot. (a) α-tubulin was used as a loading control. Cell cycle
distribution was analyzed using ﬂow cytometry. (b) Data (percentage of cells in the indicated phases) are presented as means ± SD of three
independent measurements. aP <.05, bP <.01, cP <.001, dP <.0001 versus the control group.
2.3. MTT. Cell viability was estimated using a colorimetric
assay based on the conversion oftetrazoliumdye (MTT) into
a blue formazan product. All procedures were described in
our previous study [35]. After harvesting and washing twice
with phosphate buﬀered saline (PBS), the cells were cultured
in phenol red-free DMEM (1ml) with MTT (0.5mgml
−1)
at 37◦C for 4h. The cells were incubated in isopropenol
(1ml) with shaking for 10min. Samples were aspirated and
measured spectrophotometerically at 570nm.
2.4. Western Blot. Cultured RSC96 cells were scraped and
washed once with PBS. The cell suspension was then spun
down, and cell pellets were lysed for30min in the lysisbuﬀer
(50mM Tris (pH 7.5), 0.5 M NaCl, 1.0mM EDTA (pH 7.5),
10% glycerol, 1mM BME, 1% IGEPAL-630 and proteinase
inhibitor cocktail (Roche, Mannheim, Germany)) and then
centrifuged at 12000g for 10min. The supernatants were
removed and placed in new Eppendorf tubes for western
blot analysis. Proteins from the RSC96cells were separated in
12% gradient SDS-PAGE and transferred onto nitrocellulose
membranes. Nonspeciﬁc protein binding was blocked in
the blocking buﬀer at room temperature for 1h (5% milk,
20mM Tris-HCl, pH 7.6, 150mM NaCl and 0.1% Tween
20). The membranes were incubated in 4◦Cb l o c k i n gb u ﬀer
overnight with speciﬁc antibodies (1:2000) against IGF-
I, IGF-IR (Abcam, Cambridge, UK), PI3K and Bcl2 (BD
Biosciences, San Jose, CA), pAkt (Cell Signaling Technology,
Inc., Beverly, MA), pBad, PCNA, cyclin D1, cyclin E, cyclin
A and tubulin (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). For repeated blotting, nitrocellulose membranes were
stripped with Restore western blot stripping buﬀer (Pierce
Biotechnology,Inc, Rockford,IL, USA)at room temperature
for 30min. Densitometric analysis of immunoblots was
performed using the AlphaImager 2200 digital imaging
system (Digital Imaging System, CA, USA).
Experiments were performed in triplicate.
2.5. Flow Cytometry. Cells were suspended in phosphate
buﬀered saline (PBS, pH 7.4) and ﬁxed with 70% (v/v)
ethanol at −20◦C for 12h–16h. After the ethanol was4 Evidence-Based Complementary and Alternative Medicine
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Figure3:Dilongextract inducestheexpressionofproteinsinvolved
in the cell cycle in a time-dependent manner. RSC96 cells were
stimulated for 24h in the presence of 125μgml
−1 Dilong extract.
The protein expression of cell cycle regulatory proteins cyclin A,
cyclin D1 and cyclin E were determined by western blot. α-tubulin
w a su s e da sal o a d i n gc o n t r o l .
removed, the cells were washed with PBS and then stained
for 30min with 0.005% propidium iodide (PI). Cellular PI
content was measured on a BD FACSCalibur cytometer and
data were analyzed using Modﬁt LT software.
2.6. siRNA. Double-stranded siRNA sequences targeting
PI3KmRNAwereobtainedfromDharmacon.Anon-speciﬁc
duplex (Dharmacon, Cat. D-001810-10-20) was used as a
control. RSC96 cells were cultured in 60-mm well plates in
DMEM without fetal bovine serum. Transfection of PI3K
siRNA (Dharmacon, Cat. L-080078-00) was carried out with
DharmaFECT Duo transfection reagent (Dharmacon, Inc.,
Lafayette, CO) according to the manufacture’s directions.
Speciﬁc silencing was conﬁrmed by immunoblotting with
cellular extracts after transfection.
2.7. Statistical Analysis. Statistical diﬀerences were assessed
using one-way ANOVA. P-value <.05 was considered statis-
tically signiﬁcant. Data are expressed as the mean±SD.
3.Results
3.1. Time-Dependent Proliferation and Survival of RSC Cells
Treated with Dilong. Our previous MTT assay revealed
that treatment with 125μgml
−1 Dilong extract for 24h
signiﬁcantly enhanced RSC96 cell survival and proliferation
[36]. Western blot analysis showed that the same treatment
strongly promoted IGF-1 protein-mediated cell survival
and proliferation (Figure 1). Dilong extract induced IGF-1
activation signiﬁcantly and rapidly induced the downstream
protein expression of the PI3K/Akt system in a time-
dependent manner. These results indicate that Dilong may
promote Schwann cell survival and proliferation via an IGF-
I-mediated signal pathway.
3.2. Dilong Treatment Promotes Cell Cycle G1 Progression.
To gain insight into the mechanism by which the extract
of Dilong promotes cell proliferation, we used western
blot and ﬂow cytometry to determine the proliferating
cell nuclear antigen (PCNA) protein levels and cell cycle
distribution. The results showed a time-dependent increase
in the expression of PCNA (Figure 2(a)). The representative
ﬂow histograms depicting cell cycle distribution in Schwann
cell cultures following diﬀerent time exposures to the extract
of Dilong are shown in Figure 2(b). Schwann cell exposure
to the extract of Dilong led to a signiﬁcant stimulation of
DNAsynthesis as evidencedby the increase in the number of
S phase cells and decrease in the number of G1 phase cells at
12h–16h. This ﬁnding suggests that Dilong accelerated the
G1 phase of the cell cycle.
3.3. Dilong Induces Expression of Cell Cycle Proliferative
Proteins. Cell cycle progression is tightly regulated by a
complex network of cell cycle regulatory molecules, such as
cyclins. To elucidate how Dilong modulates the cell cycle to
promote Schwann cell proliferation, we used western blot to
identify keycell cycleproteins(Figure 3). Consistent with the
cell cycle and IGF-I-mediated pathway data presented above,
the extract of Dilong treatment induced the upregulated
expression of cyclin D1, cyclin E and cyclin A protein
in a time-dependent manner. Taken together, these results
suggest that Dilong induces Schwann cell proliferation by
stimulating the expression of cyclins involved in cell cycle
progression.
3.4. RSC Cell Survival and Proliferation Enhanced by Dilong
Are Mediated through IGF-I and PI3K/Akt Signaling. To
identify the signaling cascades involved in IGF-I-mediated
survival and proliferation of Schwann cells, we tran-
siently transfected cells with PI3K siRNA. Results of the
immunoblotting assay showed that PI3K siRNA blocked the
extract of Dilong-induced expression of the anti-apoptotic
proteins pBad and Bcl2 (Figure 4(a)). Knockdown of PI3K
led to a signiﬁcant inhibition of DNA synthesis in cells
treated with the Dilong extract for 24h as evidenced by the
fact that the number of S phase proliferating cells decreased
(Figure 4(b)). These data indicate that Schwann cell survival
and proliferation are PI3K-dependent processes that are
mediated, at least in part, by IGF-I.
4.Discussion
This study was undertaken to gain insights into the mech-
anism by which Dilong extract promotes survival and pro-
liferation of Schwann cells. The coordinated events involved
in this mechanism are presented in Figure 5. Schwann cells
in the injured nerve area proliferate and form a B¨ υngner
band, which supports axonal regrowth [2]. Recent studies
havedemonstratedthatIGF-Iplaysacrucialroleinnervecell
proliferation [10]a n ds u r v i v a l[ 16]. However, the molecular
mechanism by which Dilong extract induces proliferation
and promotes survival of Schwann cells is unknown. This
study is the ﬁrst to demonstrate that extract of Dilong
promotes Schwann cell proliferation and survival in a time-
dependent manner by stimulating an increase in PCNA (a
protein that is expressed by cells during DNA synthesis
[37]).Dilongextract-induced SchwanncellproliferationandEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: PI3K knockdown inhibited Dilong extract-induced survival and proliferation. Schwann cell was transiently transfected with
100nM PI3K siRNA for 8h before Dilong extract treatment. After incubation with 125μgml
−1 Dilong extract for 24h, cells were harvested
andanalyzedbyimmunoblottingusingantibodiesagainstanti-PI3KantibodyandBcl2.(a)α-tubulinwasusedasaloadingcontrol.Cellcycle
distribution was analyzed by ﬂow cytometry. (b) Data (percentage of cells in the indicated phases) are the means±SD of three independent
measurements. #compared to control group, P=.066; ∗compared to Dilong-treated group, P=.037.
phosphorylation of the PI3K/Akt signal pathway were both
attenuated by transfection of PI3K siRNA. These assays
allowed us to examine the individual steps in the complex
signaling cascade and clearly illustrate how Dilong aﬀects
Schwann cell survival and proliferation.
Chinese herbal medicines have attracted a great deal of
attention as alternative and supplemental medicines [38].
Dilong extract has been shown to have diﬀerent biological
properties. It has also been shown to remove stasis (as
a slowing or pooling of the blood [39]) by promoting
blood circulation [40] and to enhance wound healing [23].
Lumbrokinase is a group of ﬁbrinolytic enzymes isolated
from Dilongs [22, 41]. Recent studies have shown that
the ﬁbrinolytic enzymes could dissolve blood ﬁbrin clots
[42]. Its therapeutic and preventive eﬀects for thrombosis-
related disease have been clinically conﬁrmed [43]. The anti-
inﬂammatory activity together with anti-oxidant properties
seems to be due to the high polyphenolic content in
Dilong tissue [44]. Another critical component of Dilong
extract is G-90, a glycolipoprotein mixture that exhibits
numerousbiologicalactivities. These includemitogenic[27],
antibacterial [32], ﬁbrinolytic and anticoagulant activities
[26], as well as an antioxidative eﬀect [45]. After treating
cell cultures with H2O2 for 4h, G-90 allowed the cells to6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Schematic model of the survival and proliferative eﬀects of Dilong extract on RSC96 Schwann cell. Stimulation of Schwann cell
with Dilong extract activate IGF-I signaling, leading to upregulation of the PI3K/Akt pathway and activation of the cell cycle regulatory
proteins cyclin D1, E and A, resulting in the survival and proliferation of RSC96 Schwann cell. Dotted lines indicate the hypothetical
molecular mechanism of the bioactive compound present in Dilong powder.
recover and stimulated their growth. Grdisa and Popvic et
al. suggest that G-90 can stimulate the growth of ﬁbroblasts
and epithelial cells and that it exerts an antioxidant activity,
both of which could play a role in its eﬀect on tissue repair.
G-90 could be a useful wound-healing agent [45], and it
possesses several growth factors including IGF [27]. Recent
studies have shown that it is non-allergenic and non-toxic
[28], and that it participates in tissue regeneration [30].
Theslowrateofperipheralnerveregenerationinhumans
can lead to prolonged denervation of end organs, raising the
specterofpermanent paralysis[46].Neurotrophicfactorsare
a family of growth factors that support and inﬂuence the
growth and regenerative capacity of neurons [47–50], such
as IGFs [51]. Previous studies have demonstrated that the
regeneration of mammalian peripheral nerves is dependent
on IGFs [52, 53]. Regenerating peripheral nerves express
prominent IGF-I in their advancing growth cone. It is
obvious that the increased staining of the regenerating nerve
isduetoIGF-I intheSchwann cell[54],and this increase was
associated with the proliferation of Schwann cell [55]. IGF-I,
signaling through the type I IGF receptor (IGF-IR), exerts
potent eﬀects on neuronal growth and survival [56]. The
PI3K/Aktsignaling activated by IGF-I through IGF-IR is well
known as cell proliferation and survival important pathway
[11, 14, 57, 58]. The signal cascade for upregulation of IGF-I
isresponsibleforcellsurvivalofretinalganglioncells(RGCs)
after injury, and it directly induces neurite outgrowth via a
PI3K/Akt-dependentmechanism [16, 59].
Moreover, IGF-I rescues Schwann cell from apoptosis via
PI3K signaling which is upstream from caspase activation
[60], and also requires that PI3K/Akt-mediated progression
from G1 to S phase of the cell cycle [57]. Conversely,
PI3K inhibitors blocked the anti-apoptotic and protective
eﬀects of IGF-I, demonstrating that PI3K is essential forEvidence-Based Complementary and Alternative Medicine 7
trophic factor-induced survival of Schwann cell [58, 60].
We suggested that IGFs from G-90 mixture could promote
proliferation and survival by PI3K/Akt pathway activation.
These bioactive compounds may directly mediate through
the upregulation of IGF-I to induce the phosphorylation of
PI3K/Akt pathway and subsequently promotes expression of
the anti-apoptotic proteins (pBad and Bcl2), PCNA and G1
to S phase cell cycle progression, resulting in Schwann cell
proliferation and survival promotion in nerve regeneration.
Based on these facts, we believe that certain components of
Dilong extract have cell proliferation and survival activity.
Our results demonstrate that Dilong stimulates Schwann
cell proliferation and survival through the PI3K/Akt system
mediated by IGF-I.
Proliferating cells pass through several cell cycle check-
points,suchastheG1 toStransitions. Theformercheckpoint
is considered to be the most important one in the replication
of DNA and mitosis. We thus logically speculate that the
extract of Dilong aﬀects Schwann cell proliferation via
alterations in the cell cycle progression. Progression through
theﬁrst gapphase (G1) requires cyclinD and cyclin E activity
[61]. Expression of these two cyclin proteins orchestrate
the progression of cells through G1 and into the S-phase
of the cell cycle [62, 63]. Cyclin A is required for DNA
replication in the S-phase and in mitosis initiation (M-
phase) [63]. Our data show that Dilong extract induces cell
cycle progression at the G1 to S phase transition. The time
course study revealed that Dilong extract promoted DNA
replication and growth of RSC96 cells by upregulating the
sequential expression of cyclin D1, cyclin E and cyclin A,
thereby elevating the number of cells in the S phase in a
time-dependent manner. Studies on the proliferative action
of IGF-I in cultured ﬁbroblasts [64, 65] and mammary
epithelial cells [66] indicate that IGF-I acts to stimulate
progression through G1 or the G0/G1 transition. Our data
are in agreement with the results of those studies that the
cell cycle is not only regulated by cyclins but is also mediated
by IGF-I. Collectively, we suggest that cell cycle alterations
may be critical determinants of the increased proliferation
potency of Dilong extract.
The IGF-IGFIR-Akt-Bcl2 axis stimulates tissue growth
[67] and axonal regeneration [16]. IGF in certain cells,
such as hematopoietic cells, functions as an inhibitor of
cell death [68]. We suggest that the extract of Dilong
promotes proliferation by allowing Schwann cell survival.
Activation of the PI3K/Akt pathway promotes cell survival.
Activation of Akt leads to the phosphorylation of Bad [69]
and connects a proximal survival signal with the Bcl-2family
toprotect against apoptosis.Althoughwe cannot ruleoutthe
possibility that the other minor candidates in the pathways,
we unequivocally showed that PI3K/Aktsignal proteins were
upregulated at least in part by IGF-I in RSC96 cells treated
with Dilong extract.
In conclusion, the ﬁndings of our study provide a
potential mechanism by which Dilong extract promotes
neuron regeneration. We found that cell proliferation and
survival of Schwann cells are mediated by the upregulated
expression of IGF-I and activation of the PI3K/Akt signal
pathway. The activity of Dilong extract is probably related
to its ability to induce G1 phase cell cycle progression by
altering the expression of proteins that control the cell cycle,
resulting in the upregulation of the anti-apoptotic protein.
Further analyses are needed to determine the presence of
other bioactive compounds in Dilong extract that might
promote cell survival and proliferation.
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